Corpus overview


Overview

MeSH Disease

Human Phenotype

Hypertension (4)

Obesity (2)

Pneumonia (1)

Fever (1)

Cough (1)


Transmission

Seroprevalence
    displaying 1 - 7 records in total 7
    records per page




    Comparison of Food Intakes of Diabetes MESHD, Hypertension HP Hypertension MESHD and Heart Disease Patients with Clinical Symptoms of COVID-19 and Asymptomatic TRANS Controls.

    Authors: Houra Mohseni; Shirin Amini; Behnaz Abiri; Mojtaba Kalantar

    doi:10.21203/rs.3.rs-84142/v1 Date: 2020-09-26 Source: ResearchSquare

    Background: In recent months, Coronavirus Disease MESHD 2019 (COVID-19) is a global health challenge. Nutrition is a key determining factor of health. In the present research, we assess and compare dietary food groups and nutrient supplements intake of diabetic MESHD, hypertensive MESHD and heart disease MESHD patients with clinical symptoms of COVID-19 and asymptomatic TRANS controls.Methods: This retrospective case-control research was conducted on 98 patients with diabetes MESHD, hypertension HP hypertension MESHD, and/or heart disease MESHD that 37 of them were COVID-19 positive with clinical symptoms. Dietary intakes of participants were recorded using a food frequency questionnaire (FFQ), which was designed and validated for the Iranian population.Results: 54% of all subjects had nutritional supplements consumption in the last 6 months, and there was no significant difference in the type of nutritional supplements between cases and controls. There was no significant difference in the median intake of food groups, in the last year, in metabolic syndrome MESHD patients with clinical symptoms of COVID-19 compared to controls. Crud OR shown, adequate consumption of any food groups was not associated with the occurrence of COVID-19. Conclusion: While dietary intake and nutritional supplements may be excellent promise for preventing clinical symptoms of COVID-19, however, up to now, researches are not enough for recommending these supplements above the Recommended Dietary Allowances (RDA) for prevention and/or treatment of COVID-19.

    Comparison of Food Intakes of Diabetes MESHD, Hypertension HP Hypertension MESHD and Heart Disease Patients with Clinical Symptoms of COVID-19 and Asymptomatic TRANS Controls.

    Authors: Houra Mohseni; Shirin Amini; Behnaz Abiri; Mojtaba Kalantar

    doi:10.21203/rs.3.rs-84142/v2 Date: 2020-09-26 Source: ResearchSquare

    Background: In recent months, Coronavirus Disease MESHD 2019 (COVID-19) is a global health challenge. Nutrition is a key determining factor of health. In the present research, we assess and compare dietary food groups and nutrient supplements intake of diabetic MESHD, hypertensive MESHD and heart disease MESHD patients with clinical symptoms of COVID-19 and asymptomatic TRANS controls.Methods: This retrospective case-control research was conducted on 98 patients with diabetes MESHD, hypertension HP hypertension MESHD, and/or heart disease MESHD that 37 of them were COVID-19 positive with clinical symptoms. Dietary intakes of participants were recorded using a food frequency questionnaire (FFQ), which was designed and validated for the Iranian population.Results: 54% of all subjects had nutritional supplements consumption in the last 6 months, and there was no significant difference in the type of nutritional supplements between cases and controls. There was no significant difference in the median intake of food groups, in the last year, in metabolic syndrome MESHD patients with clinical symptoms of COVID-19 compared to controls. Crud OR shown, adequate consumption of any food groups was not associated with the occurrence of COVID-19. Conclusion: While dietary intake and nutritional supplements may be excellent promise for preventing clinical symptoms of COVID-19, however, up to now, researches are not enough for recommending these supplements above the Recommended Dietary Allowances (RDA) for prevention and/or treatment of COVID-19.

    Metabolic stress MESHD and disease-stage specific basigin expression of peripheral blood SERO immune cell subsets in COVID-19 patients

    Authors: Peter J. Siska; Katrin Singer; Jana Klitzke; Nathalie Kauer; Sonja-Maria Decking; Christina Bruss; Carina Matos; Kristina Kolodova; Alic Peuker; Gabriele Schoenhammer; Johanna Raithel; Dirk Lunz; Bernhard Graf; Florian Geismann; Matthias Lubnow; Matthias Mack; Peter Hau; Christopher Bohr; Ralph Burkhardt; Andre Gessner; Bernd Salzberger; Frank Hanses; Florian Hitzenbichler; Daniel Heudobler; Florian Lueke; Tobias Pukrop; Wolfgang Herr; Daniel Wolff; Hendrik Poeck; Christoph Brochhausen; Petra Hoffmann; Michael Rehli; Marina Kreutz; Kathrin Renner

    doi:10.1101/2020.09.18.20194175 Date: 2020-09-18 Source: medRxiv

    Coronavirus disease MESHD 2019 (COVID-19) is driven by dysregulated immune responses yet the role of immunometabolism in COVID-19 pathogenesis remains unclear. By investigating 47 patients with confirmed SARS-CoV-2 infection MESHD and 16 uninfected controls, we found an immunometabolic dysregulation specific for patients with progressed disease that was reversible in the recovery phase. Specifically, T cells and monocytes exhibited increased mitochondrial mass, accumulated intracellular ROS and these changes were accompanied by disrupted mitochondrial architecture. Basigin (CD147), but not established markers of T cell activation, was up-regulated on T cells from progressed COVID-19 patients and correlated with ROS accumulation, reflected in the transcriptome. During recovery, basigin and ROS decreased to match the uninfected controls. In vitro analyses confirmed the correlation and showed a down-regulation of ROS by dexamethasone treatment. Our findings provide evidence of a basigin-related and reversible immunometabolic dysregulation MESHD in COVID-19.

    Clinical, Behavioral and Social Factors Associated with Racial Disparities in Hospitalized and Ambulatory COVID-19 Patients from an Integrated Health Care System in Georgia

    Authors: Felipe Lobelo; Alan X Bienvenida; Serena Leung; Armand N Mbanya; Elizabeth J. Leslie; Kate E Koplan; S. Ryan Shin

    doi:10.1101/2020.07.08.20148973 Date: 2020-07-10 Source: medRxiv

    Introduction: Racial and ethnic minorities have shouldered a disproportioned burden of coronavirus disease MESHD 2019 (COVID-19) infection MESHD to date in the US, but data on the various drivers of these disparities is limited. Objectives: To describe the characteristics and outcomes of COVID-19 patients and explore factors associated with hospitalization risk by race. Methods: Case series of 448 consecutive patients with confirmed COVID-19 seen at Kaiser Permanente Georgia (KPGA), an integrated health care system serving the Atlanta metropolitan area, from March 3 to May 12, 2020. KPGA members with laboratory-confirmed COVID-19. Multivariable analyses for hospitalization risk also included an additional 3489 persons under investigation (PUI) with suspected infection MESHD. COVID-19 treatment and outcomes, underlying comorbidities and quality of care management metrics, socio-demographic and other individual and community-level social determinants of health (SDOH) indicators. Results: Of 448 COVID-19 positive members, 68,3% was non-Hispanic Black (n=306), 18% non-Hispanic White (n=81) and 13,7% Other race (n=61). Median age TRANS was 54 [IQR 43-63) years. Overall, 224 patients were hospitalized, median age TRANS 60 (50-69) years. Black race was a significant factor in the Confirmed + PUI, female TRANS and male TRANS models (ORs from 1.98 to 2.19). Obesity HP was associated with higher hospitalization odds in the confirmed, confirmed + PUI, Black and male TRANS models (ORs from 1.78 to 2.77). Chronic disease MESHD control metrics ( diabetes MESHD, hypertension HP hypertension MESHD, hyperlipidemia HP hyperlipidemia MESHD) were associated with lower odds of hospitalization ranging from 48% to 35% in the confirmed + PUI and Black models. Self-reported physical inactivity was associated with 50% higher hospitalization odds in the Black and Female TRANS models. Residence in the Northeast region of Atlanta was associated with lower hospitalization odds in the Confirmed + PUI, White and female TRANS models (ORs from 0.22 to 0.64) Conclusions: We found that non-Hispanic Black KPGA members had a disproportionately higher risk of infection TRANS risk of infection TRANS infection MESHD and, after adjusting for covariates, twice the risk of hospitalization compared to other race groups. We found no significant differences in clinical outcomes or mortality across race/ethnicity groups. In addition to age TRANS, sex and comorbidity burden, pre-pandemic self-reported exercise, metrics on quality of care and control of underlying cardio-metabolic diseases MESHD, and location of residence in Atlanta were significantly associated with hospitalization risk by race groups. Beyond well-known physiologic and clinical factors, individual and community-level social indicators and health behaviors must be considered as interventions designed to reduce COVID-19 disparities and the systemic effects of racism are implemented.

    Novel Coronavirus (SARS-CoV-2) Main Protease: Molecular docking of Puerarin as a Potential inhibitor

    Authors: Oluwafemi Adeleke Ojo; Adebola Busola Ojo; Odunayo Anthonia Taiwo; Olarewaju M Oluba

    doi:10.21203/rs.3.rs-37794/v1 Date: 2020-06-24 Source: ResearchSquare

    SARS-CoV-2 a single stranded RNA virus which triggered the global pandemic Coronavirus Disease MESHD- 2019 (COVID-2019). It has infected about 2,844,712 patients and brought forth mortality rate to about 201,315 among 216 countries as cited by WHO. Drugs including Chloroquine and Hydroxychloroquine derivatives are being administered in most urgent cases; although, with probable side effects to people with metabolic disorders MESHD. Thus, unavailability of authorized drugs and treatment for this pandemic demands the research world to discover natural compounds with potency to cure it. This paper assesses the isoflavonoid puerarin from Pueraria lobata as a possible inhibitor of the main protease of SARS-COV-2 (Mpro) via in silico approach, for example molecular docking, Lipinski’s rule of five and toxicity MESHD prediction (ADME). Puerarin revealed high binding affinity with the target site of SARS-CoV-2 main protease. This compound slightly meets the criteria of Lipinski’s rule and does not possess properties that could cause adverse effects in humans thus, making puerarin a potential drug candidate to investigate for its usage against COVID-19.

    Higher Body Mass Index is an Important Risk factor in COVID-19 patients: A Systematic Review

    Authors: Vivek Singh Malik; Ravindra Khaiwal; Savita Verma Attri; Sanjay Kumar Bhadada; Meenu Singh

    doi:10.1101/2020.05.11.20098806 Date: 2020-05-18 Source: medRxiv

    Background: Globally, both obesity HP obesity MESHD and underweight are severe health risks for various diseases. The current study systematically examines the emerging evidence to identify an association between Body Mass Index (BMI) and COVID-19 disease outcome. Methods: Online literature databases (e.g., Google Scholar, PubMed, MEDLINE, EMBASE, Scopus, Medrixv and BioRixv) were screened following standard search strategy having the appropriate keyword such as Obesity HP, Underweight, BMI, Body Mass Index, 2019-nCov, COVID-19, novel coronavirus, coronavirus disease MESHD. Studies published till 20th April 2020 were included without language restriction. These studies include case reports, case series, cohort, and any other which reported BMI, overweight HP/ obesity HP obesity MESHD or underweight, and its complication with COVID-19 disease. Findings: Obesity HP plays a significant part in the pathogenesis of COVID-19 patients, though the role of BMI in the COVID-19 pandemic must not be ignored. Interpretation: Consequences of inflammation of adipose MESHD tissue has been reported as a leading cause of insulin resistance HP and hypertension HP hypertension MESHD due to metabolic dysfunction MESHD. The results of the current study show that BMI plays a significant role in COVID-19 severity in all ages TRANS, especially the elderly TRANS population. A panel should review COVID-19 patients with higher BMI and other co-morbidities, and they should be given increased vigilance, testing priority, and therapy. Further, the COVID-19 patients whose illness entered 7-10 days, age TRANS >50 yrs, and elevated CRP levels should have additional medical considerations. Recommendation: Population and patients with high BMI have moderate to high risk of medical complications with COVID-19, and hence their health status should be monitored more frequently. Keywords: Age TRANS, BMI, COVID-19, Obesity HP.

    Metabolic disturbances MESHD and inflammatory dysfunction MESHD predict severity of coronavirus disease MESHD 2019 (COVID-19): a retrospective study

    Authors: Shuke Nie; Xueqing Zhao; Kang Zhao; Zhaohui Zhang; Zhentao Zhang; Zhan Zhang

    doi:10.1101/2020.03.24.20042283 Date: 2020-03-26 Source: medRxiv

    Background: The coronavirus disease MESHD 2019 (COVID-19) is spreading worldwide with 16,558 deaths till date. Serum SERO albumin, high-density lipoprotein (HDL-C), and C-reactive protein have been known to be associated with the severity and mortality of community-acquired pneumonia HP pneumonia MESHD. However, the characteristics and role of metabolic and inflammatory indicators in COVID-19 is unclear. Methods: We included 97 hospitalized patients with laboratory-confirmed COVID-19. Epidemiological, clinical, and laboratory indices; radiological features; and treatment were analysed. The differences in the clinical and laboratory parameters between mild and severe COVID-19 patients and the role of these indicators in severity prediction of COVID-19 were investigated. Results: All were Wuhan residents with contact with confirmed COVID-19 cases. The median age TRANS was 39 years (IQR: 30-59). The most common presenting symptoms were fever HP fever MESHD (58.8%), cough HP (55.7%), and fatigue HP fatigue MESHD (33%). Other features were lymphopenia HP lymphopenia MESHD, impaired fasting glucose, hypoproteinaemia MESHD, hypoalbuminemia HP hypoalbuminemia MESHD, low high-density lipoproteinemia MESHD. Decrease in lymphocyte count, serum SERO total protein, serum SERO albumin, high-density lipoprotein cholesterol (HDL-C), ApoA1, CD3+T%, and CD8+T% were found to be valuable in predicting the transition of COVID-19 from mild to severe illness. Chest computed tomography (CT) images showed that the absorption of bilateral lung lesions synchronized with the recovery of metabolic and inflammatory indicators. Conclusions: Hypoproteinaemia, hypoalbuminemia MESHD hypoalbuminemia HP, low high-density lipoproteinemia MESHD, and decreased ApoA1, CD3+T%, and CD8+T% could predict severity of COVID-19. Lymphocyte count, total serum SERO protein, and HDL-C may be potentially useful for the evaluation of COVID-19.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.